Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Topical microbicides safe in healthy and HIV-infected men

Oct. 23, 2003

AlphaVax receives new award from NIAID

Oct. 23, 2003

Lexiva, the only protease inhibitor offering flexible dosing, approved in U.S.

Oct. 22, 2003

Locus licenses novel gp41 crystal structure

Oct. 21, 2003

Stampidine as a potential nonspermicidal anti-HIV microbicide

Oct. 17, 2003

Phase III IND filed for interferon alfa lozenges for oral warts in HIV patients

Oct. 17, 2003

Intravaginal WHI-07 safe in pregnant rabbits and fetuses following short-term administration

Oct. 16, 2003

IPM grant to advance cyanovirin-N development

Oct. 15, 2003

Fast track status for TNX-355

Oct. 13, 2003

License agreement for use of Amplivax in novel HIV vaccine candidate

Oct. 13, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...